Author Correction: Clinical Validation of Targeted and Untargeted Metabolomics Testing for Genetic Disorders: A 3 Year Comparative Study.

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 Jul 2020
Historique:
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 9 7 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41598-020-68532-y PMID: 32636473 PMC: PMC7341886
pubmed: 32636473
doi: 10.1038/s41598-020-68532-y
pii: 10.1038/s41598-020-68532-y
pmc: PMC7341886
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

11160

Commentaires et corrections

Type : ErratumFor

Auteurs

Naif A M Almontashiri (NAM)

Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Faculty of Applied Medical Sciences and the Center for Genetics and Inherited Disorders, Taibah University, Almadinah Almunwarah, Saudi Arabia.

Li Zha (L)

Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Kim Young (K)

Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Terence Law (T)

Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Mark D Kellogg (MD)

Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Olaf A Bodamer (OA)

Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard University and MIT, Cambridge, MA, USA.

Roy W A Peake (RWA)

Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Roy.Peake@childrens.harvard.edu.

Classifications MeSH